Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Samuel Peña-Llopis

8PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Aug 04, 2025
Autophagy suppression via SRC induction represents a therapeutic vulnerability for <i>BAP1</i>-mutant cancers.

Silvia Vega-Rubin-de-Celis, Amanda Kristani, Matthias Kudla

|Jun 26, 2025
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.

Monika Raab, Khayal Gasimli, Balázs Győrffy

|May 20, 2025
Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.

Monika Raab, Balázs Győrffy, Samuel Peña-Llopis

|Dec 23, 2023
Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.

Monika Raab, Izabela Kostova, Samuel Peña-Llopis

|Feb 22, 2023
Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.

Ranadip Mandal, Monika Raab, Franz Rödel

|Nov 18, 2022
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.

Ranadip Mandal, Monika Raab, Franz Rödel

Pageof 2

Frequent Collaborators

4 joint publications

Mourad Sanhaji

3 joint publications

Svenja Mergener

3 joint publications

Klaus Strebhardt

2 joint publications

Ranadip Mandal

2 joint publications

Franz Rödel

1 joint publications

Jens T Siveke

1 joint publications

Gioele Medici

1 joint publications

Khayal Gasimli

1 joint publications

Balázs Győrffy

1 joint publications

Silvia Vega-Rubin-de-Celis

Frequent Collaborators

4 joint publications

Mourad Sanhaji

3 joint publications

Svenja Mergener

3 joint publications

Klaus Strebhardt

2 joint publications

Ranadip Mandal

Top Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on : Jun 30, 2023

1.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos

Top Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on : Jun 30, 2023

1.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos